Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Juni 2018 11:30 ET | Quelle: Transplant Genomics Inc.

Studies Presented at American Transplant Congress Support Clinical Utility of TGI’s TruGraf® Tests for Management of Kidney Transplant Recipients

Mansfield, MA, June 12, 2018 (GLOBE NEWSWIRE) -- Last week Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, presented data at the...
28. November 2017 11:51 ET | Quelle: Transplant Genomics Inc.

Clinical Utility Study Indicates Potential for TruGraf™ Test to Replace Surveillance Biopsies in Kidney Transplant Recipients with Stable Renal Function

Mansfield, Nov. 28, 2017 (GLOBE NEWSWIRE) -- MANSFIELD, MA – Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, has published a...
24. Oktober 2017 09:24 ET | Quelle: Transplant Genomics Inc.

Study Shows TruGraf Blood Test Enables Non-invasive Detection of Immune Quiescent Kidney Transplant Recipients

Mansfield, Oct. 24, 2017 (GLOBE NEWSWIRE) -- MANSFIELD, MA – Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, announces a publication...
29. September 2017 08:00 ET | Quelle: Transplant Genomics Inc.

U.S. patent issues for gene expression profiles associated with chronic kidney allograft rejection, licensed exclusively to Transplant Genomics Inc

Mansfield, MA, Sept. 29, 2017 (GLOBE NEWSWIRE) -- U.S. patent issues for gene expression profiles associated with chronic kidney allograft rejection, licensed exclusively to Transplant Genomics...